$AVNI
ARVANA INC

2024 Q3 Form 10-Q Financial Statement

#000171328224000945 Filed on August 21, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $6.134K $13.83K
YoY Change -42.02% 1.85%
Cost Of Revenue $15.76K
YoY Change 7.72%
Gross Profit -$1.930K
YoY Change 83.81%
Gross Profit Margin -13.96%
Selling, General & Admin $129.8K
YoY Change 19.39%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.713K $6.711K
YoY Change 14.73% 14.7%
% of Gross Profit
Operating Expenses $101.8K $152.2K
YoY Change -20.31% 23.44%
Operating Profit -$95.64K -$138.4K
YoY Change -18.35% 26.12%
Interest Expense -$19.42K
YoY Change -217.53%
% of Operating Profit
Other Income/Expense, Net -$6.078K -$7.414K
YoY Change 69.12% 63.95%
Pretax Income -$145.8K
YoY Change 27.61%
Income Tax
% Of Pretax Income
Net Earnings -$101.7K -$145.8K
YoY Change -15.75% 27.61%
Net Earnings / Revenue -1658.2% -1054.4%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.8M shares 107.8M shares
Diluted Shares Outstanding 107.8M shares 107.8M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.23K
YoY Change -12.98%
Cash & Equivalents $9.257K $16.23K
Short-Term Investments
Other Short-Term Assets $100.00 $5.100K
YoY Change -98.04% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.357K $21.33K
YoY Change -42.9% -10.21%
LONG-TERM ASSETS
Property, Plant & Equipment $143.2K $150.0K
YoY Change -14.17% -10.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $169.2K $176.0K
YoY Change -12.26% -8.83%
TOTAL ASSETS
Total Short-Term Assets $9.357K $21.33K
Total Long-Term Assets $169.2K $176.0K
Total Assets $178.6K $197.3K
YoY Change -14.66% -8.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.35K
YoY Change 7.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $769.1K $781.3K
YoY Change 1567.92% 1945.68%
Total Short-Term Liabilities $1.233M $1.204M
YoY Change 512.9% 823.29%
LONG-TERM LIABILITIES
Long-Term Debt $125.8K
YoY Change -85.83%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $134.2K $125.8K
YoY Change -84.74% -85.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.233M $1.204M
Total Long-Term Liabilities $134.2K $125.8K
Total Liabilities $1.367M $1.329M
YoY Change 26.49% 30.59%
SHAREHOLDERS EQUITY
Retained Earnings -$37.93M -$37.83M
YoY Change 1.42% 1.47%
Common Stock $36.75M $36.70M
YoY Change 0.58% 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.336K $3.336K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$1.188M -$1.132M
YoY Change
Total Liabilities & Shareholders Equity $178.6K $197.3K
YoY Change -14.66% -8.98%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$101.7K -$145.8K
YoY Change -15.75% 27.61%
Depreciation, Depletion And Amortization $6.713K $6.711K
YoY Change 14.73% 14.7%
Cash From Operating Activities -$176.3K
YoY Change 219.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 58.47K
YoY Change 162.55%
NET CHANGE
Cash From Operating Activities -176.3K
Cash From Investing Activities 0.000
Cash From Financing Activities 58.47K
Net Change In Cash -117.8K
YoY Change 258.12%
FREE CASH FLOW
Cash From Operating Activities -$176.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839229 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839299 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107839229 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-749971 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
62488 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-114269 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-801252 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1031707 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
45428 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-145823 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1132102 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104495 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
136922 usd
us-gaap Net Income Loss
NetIncomeLoss
-1042669 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-801252 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-962126 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
105284 usd
us-gaap Net Income Loss
NetIncomeLoss
-275260 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1132102 usd
us-gaap Net Income Loss
NetIncomeLoss
-275260 usd
us-gaap Net Income Loss
NetIncomeLoss
-1042669 usd
us-gaap Depreciation
Depreciation
13422 usd
us-gaap Depreciation
Depreciation
11701 usd
us-gaap Share Based Compensation
ShareBasedCompensation
105284 usd
us-gaap Share Based Compensation
ShareBasedCompensation
136922 usd
AVNI Loss On Purchase Of Assets
LossOnPurchaseOfAssets
0 usd
AVNI Loss On Purchase Of Assets
LossOnPurchaseOfAssets
771009 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-29102 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19091 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-45600 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
4656 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-231256 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99290 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
50000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
4089 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45911 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
25266 usd
AVNI Payments On Loans Payable
PaymentsOnLoansPayable
12589 usd
AVNI Payments On Loans Payable
PaymentsOnLoansPayable
3779 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
370000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
-0 usd
AVNI Payments For Loans Related Party
PaymentsForLoansRelatedParty
132000 usd
AVNI Payments For Loans Related Party
PaymentsForLoansRelatedParty
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
225411 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21487 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5845 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-123714 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22071 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142365 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16226 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18651 usd
us-gaap Interest Paid Net
InterestPaidNet
30087 usd
us-gaap Interest Paid Net
InterestPaidNet
6724 usd
AVNI Note Payable Issued For Asset Acquisition
NotePayableIssuedForAssetAcquisition
0 usd
AVNI Note Payable Issued For Asset Acquisition
NotePayableIssuedForAssetAcquisition
700000 usd
AVNI Liabilities Assumed In Asset Acquisition
LiabilitiesAssumedInAssetAcquisition
0 usd
AVNI Liabilities Assumed In Asset Acquisition
LiabilitiesAssumedInAssetAcquisition
234904 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zp6RZ67RIu5i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zl8tQRmMX3Yl">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences. </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zc86k4szmbU9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_861_zQMEN3DKEWP8">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. At June 30, 2024 and December 31, 2023 respectively, the Company did not have any cash in excess of the insured FDIC limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank account.</span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7950000 shares
us-gaap Net Income Loss
NetIncomeLoss
-275260 usd
us-gaap Net Income Loss
NetIncomeLoss
-1042669 usd
CY2024Q2 AVNI Working Capital
WorkingCapital
1182305 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37832201 usd
CY2023 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
4089 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
5100 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
178706 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Commercial Fishing License
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommercialFishingLicense
26000 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
213895 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
4910 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
644 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Payable To Affiliates
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayableToAffiliates
62634 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Notes Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable
166716 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
234904 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
750000 usd
CY2023Q1 AVNI Business Combination Loss On Asset Acquisition
BusinessCombinationLossOnAssetAcquisition
771009 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
187347 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
187347 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37391 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23969 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
149956 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
163378 usd
us-gaap Depreciation
Depreciation
13422 usd
us-gaap Depreciation
Depreciation
11701 usd
CY2024Q2 us-gaap Depreciation
Depreciation
6711 usd
CY2023Q2 us-gaap Depreciation
Depreciation
5851 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
4000 usd
CY2024Q2 us-gaap Lease Income
LeaseIncome
12000 usd
us-gaap Lease Income
LeaseIncome
24000 usd
CY2023Q2 us-gaap Lease Income
LeaseIncome
12000 usd
us-gaap Lease Income
LeaseIncome
20000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
24000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
52000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
76000 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30000 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
600 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1200 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
132000 usd
CY2023 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
AVNI Notes Issued Interest Bearing
NotesIssuedInterestBearing
300000 usd
AVNI Notes Issued Non Interest Bearing
NotesIssuedNonInterestBearing
50000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7950000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
105284 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
249952 usd
AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
247337 usd
AVNI Share Based Compensation Expense Remainder Of Fiscal Year
ShareBasedCompensationExpenseRemainderOfFiscalYear
90856 usd
AVNI Share Based Compensation Expense Next Twelve Months
ShareBasedCompensationExpenseNextTwelveMonths
151848 usd
AVNI Share Based Compensation Expense Year Two
ShareBasedCompensationExpenseYearTwo
2527 usd
AVNI Share Based Compensation Expense Year Three
ShareBasedCompensationExpenseYearThree
2106 usd
AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
247337 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
1257037 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1031626 usd
CY2024Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
781285 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
79438 usd
CY2024Q2 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
350000 usd
CY2023Q4 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
112000 usd
CY2024Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
125752 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
840188 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
81285 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1069136 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9076 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7730 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8287 usd
CY2024Q2 AVNI Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
81523 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1257037 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001713282-24-000945-index-headers.html Edgar Link pending
0001713282-24-000945-index.html Edgar Link pending
0001713282-24-000945.txt Edgar Link pending
0001713282-24-000945-xbrl.zip Edgar Link pending
avni-20240630.xsd Edgar Link pending
avni063024form10q.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
avni-20240630_def.xml Edgar Link unprocessable
avni-20240630_cal.xml Edgar Link unprocessable
avni-20240630_lab.xml Edgar Link unprocessable
avni-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avni063024form10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending